| abstract |
FIELD: medicine. n SUBSTANCE: group of inventions refers to medicine, more specifically to a biodegradable non-woven material containing (i) at least one polymer for inducing primary haemostasis, (ii) at least one non-proteinogenic, water-soluble secondary haemostasis activator at (iii) least one non-proteinogenic, water-soluble fibrinolysis inhibitor. Method for producing a biodegradable non-woven material is described, wherein (i) a fluidised raw fibre material is placed in a container, optionally along with additives, (ii) container is set in rotation, (iii) fluidised raw fibre material is discharged from the container by means of centrifugal forces, as a result of which fibres or filaments are formed, and (iv) a biodegradable non-woven material is formed from the fibres or filaments. n EFFECT: use of biodegradable non-woven material formed so that human fibroblasts can penetrate into non-woven material and so that the connective tissue can form in the course of wound healing. n 13 cl, 4 dwg, 3 ex |